Prescribed medications in patients in different group of antiviral treatment and incidence of acute kidney injury.

Raymond R Townsend
Debbie L Cohen
Raymond R Townsend

January 2014

of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of a...

The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database

Kalin M. Clifford
Ashley R. Selby
Kelly R. Reveles
Chengwen Teng
Ronald G. Hall
Jamie McCarrell
Carlos A. Alvarez

October 2022

Antibiotic-associated acute kidney injury (AA-AKI) is quite common, especially among hospitalized pa...

Antiviral composition of outpatients prescribed antivirals with different insurance types from 2008–2012.

Qian Qiu (331716)
Yan Li (23143)
Xiao-wan Duan (645908)
Li-kun Yang (645909)
Yu Chen (29959)
Hui Li (32376)
Li Wang (15202)
Zhong-Ping Duan (469184)

October 2014

*Note: some patients treated with more than one antiviral at the same time may increase the sum o...

Mortality, intensive care unit admission and prolonged hospitalization of patients included in the study based on different categories of antiviral treatment and incidence of acute kidney injury.

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

Mortality, intensive care unit admission and prolonged hospitalization of patients included in the s...

Clinical characteristics of patients included in the study based on antiviral treatment and incidence of acute kidney injury.

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

Clinical characteristics of patients included in the study based on antiviral treatment and incidenc...

Logistic regression and odds ratio for different category of antiviral treatment and incidence of acute kidney injury and mortality, intensive care unit admission and prolonged hospitalization.

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

Logistic regression and odds ratio for different category of antiviral treatment and incidence of ac...

Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome.

Hossein Khalili
Samaneh Bairami
Mona Kargar

December 2013

Drug induced acute kidney injury (AKI) has been implicated in 8% to 60% of all cases of in-hospital ...

Nefrotoxicidade dos antivíricos.

Neto, Ricardo
Oliveira, Gerardo
Pestana, Manuel

January 2007

Antiviral drug-induced kidney injury, frequently leading to acute renal failure, is increasing in in...

Acute kidney injury patient distribution treated with extended daily dialysis according to outcome and metabolic and fluid control.

Daniela Ponce (495620)
Juliana Maria Gera Abrão (495621)
Bianca Ballarin Albino (495622)
André Luis Balbi (495623)

December 2013

Acute kidney injury patient distribution treated with extended daily dialysis according to outcom...

Percent of main outcome in patients by different category of nephrotoxic treatment and incidence of acute kidney injury (AKI).

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

(Group 1: Without AKI and without antiviral medications (n = 362); Group 2: Without AKI and with ant...

Kaplan Maier survival time of patients based on different category of antiviral treatment and incidence of acute kidney injury (AKI).

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

(Group 1: Without AKI and Without antiviral medications (n = 362); Group 2: Without AKI and with ant...

The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

Eun Ju Lee
Ha Nee Jang
Hyun Seop Cho
Eunjin Bae
Tae Won Lee
Se-Ho Chang
Dong Jun Park

October 2018

Intravenous (IV) acyclovir is commonly administered medication for viral infection but is well known...

Medication prescriptions in 149 patients with end-stage renal disease, stratified by renal replacement therapy.

Thijs T. Jansz (5703437)
Aegida Neradova (5703440)
Adriana J. van Ballegooijen (451317)
Marianne C. Verhaar (137865)
Marc G. Vervloet (829815)
Leon J. Schurgers (123737)
Brigit C. van Jaarsveld (5703443)

August 2018

Medication prescriptions in 149 patients with end-stage renal disease, stratified by renal replaceme...

Profile of prescribed medications for chronic kidney disease patients attending the renal clinic of Tikur Anbessa Specialized Hospital.

Belayneh Kefale (5558855)
Yewondwossen Tadesse (5558852)
Minyahil Alebachew (5258672)
Ephrem Engidawork (3485660)

July 2018

Profile of prescribed medications for chronic kidney disease patients attending the renal clinic ...

Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients.

Johanna Schneider
Bernd Jaenigen
Dirk Wagner
Siegbert Rieg
Daniel Hornuss
Paul M Biever
Winfried V Kern
Gerd Walz

January 2021

BackgroundAcute kidney injury (AKI) is an independent risk factor for mortality, which affects about...

Personnal correspondence

Raymond R Townsend
Debbie L Cohen
Raymond R Townsend

January 2014

of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of a...

The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database

Kalin M. Clifford
Ashley R. Selby
Kelly R. Reveles
Chengwen Teng
Ronald G. Hall
Jamie McCarrell
Carlos A. Alvarez

October 2022

Antibiotic-associated acute kidney injury (AA-AKI) is quite common, especially among hospitalized pa...

Antiviral composition of outpatients prescribed antivirals with different insurance types from 2008–2012.

Qian Qiu (331716)
Yan Li (23143)
Xiao-wan Duan (645908)
Li-kun Yang (645909)
Yu Chen (29959)
Hui Li (32376)
Li Wang (15202)
Zhong-Ping Duan (469184)

October 2014

*Note: some patients treated with more than one antiviral at the same time may increase the sum o...

Mortality, intensive care unit admission and prolonged hospitalization of patients included in the study based on different categories of antiviral treatment and incidence of acute kidney injury.

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

Mortality, intensive care unit admission and prolonged hospitalization of patients included in the s...

Clinical characteristics of patients included in the study based on antiviral treatment and incidence of acute kidney injury.

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

Clinical characteristics of patients included in the study based on antiviral treatment and incidenc...

Logistic regression and odds ratio for different category of antiviral treatment and incidence of acute kidney injury and mortality, intensive care unit admission and prolonged hospitalization.

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

Logistic regression and odds ratio for different category of antiviral treatment and incidence of ac...

Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome.

Hossein Khalili
Samaneh Bairami
Mona Kargar

December 2013

Drug induced acute kidney injury (AKI) has been implicated in 8% to 60% of all cases of in-hospital ...

Nefrotoxicidade dos antivíricos.

Neto, Ricardo
Oliveira, Gerardo
Pestana, Manuel

January 2007

Antiviral drug-induced kidney injury, frequently leading to acute renal failure, is increasing in in...

Acute kidney injury patient distribution treated with extended daily dialysis according to outcome and metabolic and fluid control.

Daniela Ponce (495620)
Juliana Maria Gera Abrão (495621)
Bianca Ballarin Albino (495622)
André Luis Balbi (495623)

December 2013

Acute kidney injury patient distribution treated with extended daily dialysis according to outcom...

Percent of main outcome in patients by different category of nephrotoxic treatment and incidence of acute kidney injury (AKI).

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

(Group 1: Without AKI and without antiviral medications (n = 362); Group 2: Without AKI and with ant...

Kaplan Maier survival time of patients based on different category of antiviral treatment and incidence of acute kidney injury (AKI).

Seyed Majid Mousavi Movahed (17131645)
Hamed Akhavizadegan (17131648)
Fatemeh Dolatkhani (17131651)
Samaneh Akbarpour (668065)
Seyed Aria Nejadghaderi (11651651)
Morvarid Najafi (17131654)
Parmida Sadat Pezeshki (15463046)
Akram Khalili Noushabadi (17131657)
Hoomaan Ghasemi (17131660)

October 2023

(Group 1: Without AKI and Without antiviral medications (n = 362); Group 2: Without AKI and with ant...

The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

Eun Ju Lee
Ha Nee Jang
Hyun Seop Cho
Eunjin Bae
Tae Won Lee
Se-Ho Chang
Dong Jun Park

October 2018

Intravenous (IV) acyclovir is commonly administered medication for viral infection but is well known...

Medication prescriptions in 149 patients with end-stage renal disease, stratified by renal replacement therapy.

Thijs T. Jansz (5703437)
Aegida Neradova (5703440)
Adriana J. van Ballegooijen (451317)
Marianne C. Verhaar (137865)
Marc G. Vervloet (829815)
Leon J. Schurgers (123737)
Brigit C. van Jaarsveld (5703443)

August 2018

Medication prescriptions in 149 patients with end-stage renal disease, stratified by renal replaceme...

Profile of prescribed medications for chronic kidney disease patients attending the renal clinic of Tikur Anbessa Specialized Hospital.

Belayneh Kefale (5558855)
Yewondwossen Tadesse (5558852)
Minyahil Alebachew (5258672)
Ephrem Engidawork (3485660)

July 2018

Profile of prescribed medications for chronic kidney disease patients attending the renal clinic ...

Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients.

Johanna Schneider
Bernd Jaenigen
Dirk Wagner
Siegbert Rieg
Daniel Hornuss
Paul M Biever
Winfried V Kern
Gerd Walz

January 2021

BackgroundAcute kidney injury (AKI) is an independent risk factor for mortality, which affects about...

Personnal correspondence

Raymond R Townsend
Debbie L Cohen
Raymond R Townsend

January 2014

of diuretics with ACE inhibitors or angiotensin receptor blockers and NSAIDs increases the risk of a...

The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database

Kalin M. Clifford
Ashley R. Selby
Kelly R. Reveles
Chengwen Teng
Ronald G. Hall
Jamie McCarrell
Carlos A. Alvarez

October 2022

Antibiotic-associated acute kidney injury (AA-AKI) is quite common, especially among hospitalized pa...

Antiviral composition of outpatients prescribed antivirals with different insurance types from 2008–2012.

Qian Qiu (331716)
Yan Li (23143)
Xiao-wan Duan (645908)
Li-kun Yang (645909)
Yu Chen (29959)
Hui Li (32376)
Li Wang (15202)
Zhong-Ping Duan (469184)

October 2014

*Note: some patients treated with more than one antiviral at the same time may increase the sum o...

Prescribed medications in patients in different group of antiviral treatment and incidence of acute kidney injury.

Abstract

Extracted data

Prescribed medications in patients in different group of antiviral treatment and incidence of acute kidney injury.

Abstract

Extracted data

Related items

Related items